FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / PURCHASE ORDER

BREAST CANCER SURVIVORS COHORT LATE EFFECTS OF BREAST CANCER TREATMENTS

Awarded to KAISER FOUNDATION HOSPITALS

PIID 75N91020P00327US · USAspendingNot reported
$150K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$149,998sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateApr 1, 2020
Company legal name
KAISER FOUNDATION HOSPITALS
UEI / CAGE
P1RTMASB37B5 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
National Institutes of Health
Industry
Not reported
NAICS
541690
PSC
B529
Performance period
Not reported — Not reported
Recipient address
1800 HARRISON ST FL 16, OAKLAND, ALAMEDA, CA, 94612
Place of performance
ROCKVILLE, MONTGOMERY, MD, 20850
Source last modified
Oct 21, 2026

Description

BREAST CANCER SURVIVORS COHORT LATE EFFECTS OF BREAST CANCER TREATMENTS

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    BREAST CANCER SURVIVORS COHORT LATE EFFECTS OF BREAST CANCER TREATMENTS

    US · usaspendingSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Mar 31, 20200Not reported$149,998.00Not reportedNot reportedBREAST CANCER SURVIVORS COHORT LATE EFFECTS OF BREAST CANCER TREATMENTSUSAspending ↗